Açık Akademik Arşiv Sistemi

Coronavirus Disease (COVID-19), Chemical Structure, Therapeutics, Drugs and Vaccines

Show simple item record

dc.contributor.authors Atiroglu, Vesen; Atiroglu, Atheer; Ozsoy, Munteha; Ozacar, Mahmut
dc.date.accessioned 2023-01-24T12:09:03Z
dc.date.available 2023-01-24T12:09:03Z
dc.date.issued 2022
dc.identifier.issn 2069-5837
dc.identifier.uri http://dx.doi.org/10.33263/BRIAC121.547566
dc.identifier.uri https://hdl.handle.net/20.500.12619/99766
dc.description Bu yayın 06.11.1981 tarihli ve 17506 sayılı Resmî Gazete’de yayımlanan 2547 sayılı Yükseköğretim Kanunu’nun 4/c, 12/c, 42/c ve 42/d maddelerine dayalı 12/12/2019 tarih, 543 sayılı ve 05 numaralı Üniversite Senato Kararı ile hazırlanan Sakarya Üniversitesi Açık Bilim ve Açık Akademik Arşiv Yönergesi gereğince telif haklarına uygun olan nüsha açık akademik arşiv sistemine açık erişim olarak yüklenmiştir.
dc.description.abstract Biochemistry has the main role to play in understanding the structure of viral to develop techniques and materials used by clinicians, virologists, and researchers, as well as isolation of therapies and vaccines. Biochemistry helps to understand the molecules that manage virus structure and function can accelerate discovering means to treat and avoid infectious disease. The significant contributions of biochemistry are providing to understanding and monitoring the spread of coronaviruses. COVID-19 is a novel type of coronavirus influence humans and was recognized in 2019. The terms severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), 2019 novel coronavirus, and COVID-19 mention the same virus. All present medication choices are based on experience with MERS, SARS, and other new influenza viruses. Thus, it is essential to understand the virus structure and its clinical features to respond to the COVID-19 outbreak. Intensive studies are currently being carried out to develop specific drugs or vaccines for the COVID-19 coronavirus. This study will shed light on the various present and future research efforts to treat the COVID-19 by evaluating past studies to assist the therapeutics for COVID-19 improve quickly.
dc.language English
dc.language.iso eng
dc.publisher AMG TRANSCEND ASSOC
dc.relation.isversionof 10.33263/BRIAC121.547566
dc.subject Chemistry
dc.subject Coronavirus 2019-nCoV
dc.subject diagnosis
dc.subject COVID-19
dc.subject viruses
dc.subject infectious diseases
dc.title Coronavirus Disease (COVID-19), Chemical Structure, Therapeutics, Drugs and Vaccines
dc.type Review
dc.contributor.authorID ATiROĞLU, Vesen/0000-0001-7551-133X
dc.identifier.volume 12
dc.identifier.startpage 547
dc.identifier.endpage 566
dc.relation.journal BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY
dc.identifier.issue 1
dc.identifier.doi 10.33263/BRIAC121.547566
dc.contributor.author Atiroglu, Vesen
dc.contributor.author Atiroglu, Atheer
dc.contributor.author Ozsoy, Munteha
dc.contributor.author Ozacar, Mahmut
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rights.openaccessdesignations gold


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record